Rosalind Chuang, MD

Movement disorders specialist

Clinical Assistant Professor, Neurology & Neurological Sciences

Movement Disorders Center

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6469
Learn More About the Clinic Getting Here Make An Appointment

Deep Brain Stimulation Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6469
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Medical Education: University of Washington School of Medicine (2003) WA

Board Certification: Neurology, American Board of Psychiatry and Neurology (2009)

Fellowship: University of Toronto (2010) ONCanada

Fellowship, Toronto Western Hospital, Movement Disorders (2009)

Residency: University of Washington (2007) WA

Internship: University of Washington School of Medicine (2004) WA

Parallel PARKing: Parkinson's Genes Function in Common Pathway
Chuang, R. S., & Gitler, A. D. (2013). Parallel PARKing: Parkinson's Genes Function in Common Pathway. NEURON, 77(3), 377-379.

Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
Marras, C., Schuele, B., Munhoz, R. P., Rogaeva, E., Langston, J. W., & Lang, A. E. (2011). Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. NEUROLOGY, 77(4), 325-333.

Rasagiline-Induced Spontaneous Ejaculation
Chuang, R. S., & Lang, A. E. (2009). Rasagiline-Induced Spontaneous Ejaculation. MOVEMENT DISORDERS, 24(14), 2160-2161.

Serotonin and Parkinson's disease: On movement, mood, and madness.
Fox S, Chuang R, & Brotchie J. (2009). Serotonin and Parkinson's disease: On movement, mood, and madness. Movement Disorders, 24(9).

Myoclonus-dystonia: Significance of large SGCE deletions
Grunewald, A., Djarmati, A., Lohmann-Hedrich, K., Farrell, K., Zeller, J. A., & Klein, C. (2008). Myoclonus-dystonia: Significance of large SGCE deletions. HUMAN MUTATION, 29(2), 331-332.

Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy
Fox S, Chuang R, & Brotchie J. (2008). Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy. Prog Brain Res, 172.

Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin
Chuang, R. Si., Jaffe, H., Cribbs, L., Perez-Reyes, E., & Swartz, K. J. (1998). Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin. NATURE NEUROSCIENCE, 1(8), 668-674.